- TV Footage
- Financial Reports
- Newsletter Overview
- Social Media
- Media Contact
Leverkusen, October 1, 2019 – The Local Court of Cologne has appointed Ertharin Cousin as a member of the Supervisory Board of Bayer AG. Cousin, a U.S. citizen who holds a doctorate in law, served as executive director of the UN World Food Programme in Rome from 2012 until 2017 and is an internationally renowned expert in the area of nutrition and agriculture. The new appointment gives the Bayer Supervisory Board the added support it was targeting in view of the growing significance of the Crop Science business. “We are delighted to have such an outstanding person as Ertharin Cousin take on this task. Her exceptional experience in the area of nutrition, government and the United Nations makes her an ideal addition to the Supervisory Board,” said Werner Wenning, Chairman of the Supervisory Board of Bayer AG.
Cousin will succeed Thomas Ebeling, who stepped down at the end of September to pursue new commitments at other companies. His term of office was not scheduled to end until 2022. “We would like to thank Mr. Ebeling for his outstanding and trusting cooperation,” continued Wenning.
Ertharin Cousin is currently a Distinguished Fellow at the Chicago Council on Global Affairs, a think tank dedicated to topics such as global food security and nutrition, urbanization, energy and water supply. Cousin also serves as a Visiting Scholar in the Stanford University Freeman Spogli Institute for International Studies, Center for Food Security and Environment. Before taking up her position as executive director of the UN World Food Programme, Cousin was appointed as the U.S. ambassador to the UN Agencies for Food and Agriculture from 2009 to 2012. During her career, Cousin also served as the Executive Vice President and Chief Operating Officer of the aid organization America’s Second Harvest (now called Feeding America). She also worked in several corporate leadership roles including Senior Vice President of Public Affairs and Chief Information Officer at the U.S. supermarket chain Albertsons. During the Clinton administration, she served as the White House Liaison to the State Department, where she earned a Meritorious Service Award for her work. From 1987 to 1989, she held various positions at the Illinois Attorney General’s office, including Assistant Attorney General.
“Ertharin Cousin has dedicated her career to the fight against hunger,” said Wenning. “We have a common vision to provide a sustainable food supply for the growing world population and to eradicate hunger. That takes innovation and technological advances, and means many different people working together on many different levels. Ertharin Cousin’s expertise and her international experience at the interface between government, business, academia and civil society organizations will give our company a new perspective.”
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.